PhRMA DRAFT HEALTH OUTCOMES PERFORMANCE MEASURES WILL INSURE VALUE OF PHARMACEUTICAL THERAPY IS CONSIDERED, TEAM LEADER SAYS; AHCPR UNVEILS "CONQUEST"
Executive Summary
The Pharmaceutical Research & Manufacturers of America draft performance measures for seven chronic diseases are designed "to insure that the value of pharmaceuticals are included in the development of performance measures," PhRMA Health Outcomes working group Chairman and Lilly Senior Health Economics Research Physician James Kotsanos, MD, told the Center for Pharmaceutical Outcomes Research 1996 conference at the University of North Carolina-Chapel Hill April 1.